• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Cinnolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Cinnolines

Introduction to 5-Bromocinnoline (CAS No. 24257-88-3)

5-Bromocinnoline, with the CAS number 24257-88-3, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of cinnolines, which are characterized by their unique heterocyclic structure. The presence of a bromine atom at the 5-position of the cinnoline ring imparts distinct chemical and biological properties, making it a valuable intermediate in the synthesis of various pharmaceuticals and agrochemicals.

The chemical structure of 5-Bromocinnoline consists of a six-membered ring with a nitrogen atom and a double bond, along with a bromine substituent. This configuration provides a platform for diverse chemical reactions, including nucleophilic substitution, coupling reactions, and functional group modifications. These reactions are crucial in the development of novel compounds with potential therapeutic applications.

Recent studies have highlighted the importance of 5-Bromocinnoline in the synthesis of bioactive molecules. For instance, researchers at the University of California, San Francisco, have utilized this compound as a key intermediate in the development of new antiviral agents. The bromine substituent facilitates the formation of stable intermediates that can be further modified to enhance antiviral activity. This approach has shown promising results in preclinical studies, demonstrating significant inhibition of viral replication in cell cultures.

In addition to its role in antiviral drug development, 5-Bromocinnoline has also been explored for its potential in cancer therapy. A study published in the Journal of Medicinal Chemistry reported that derivatives of 5-Bromocinnoline exhibit potent anticancer activity against various cancer cell lines. The researchers found that these derivatives can selectively target and inhibit specific enzymes involved in cancer cell proliferation, thereby reducing tumor growth and metastasis.

The synthetic versatility of 5-Bromocinnoline extends beyond pharmaceutical applications. In the field of agrochemistry, this compound has been used as an intermediate in the synthesis of pesticides and herbicides. Its ability to form stable complexes with metal ions makes it suitable for developing environmentally friendly agrochemicals that are effective at low concentrations. This is particularly important in addressing the growing concerns about the environmental impact of traditional pesticides.

The physical and chemical properties of 5-Bromocinnoline have been extensively studied to optimize its use in various applications. It is a solid at room temperature with a melting point ranging from 110 to 112°C. The compound is soluble in common organic solvents such as dimethylformamide (DMF) and dimethyl sulfoxide (DMSO), which facilitates its use in solution-phase reactions. Its stability under various reaction conditions makes it an ideal choice for multi-step synthetic processes.

In terms of safety and handling, while 5-Bromocinnoline is not classified as a hazardous material, it is important to follow standard laboratory safety protocols when working with this compound. Proper personal protective equipment (PPE) should be worn, and experiments should be conducted in well-ventilated areas to minimize exposure risks.

The market demand for 5-Bromocinnoline has been steadily increasing due to its wide range of applications. Pharmaceutical companies and research institutions are continuously exploring new ways to utilize this compound in drug discovery and development processes. The global market for cinnolines and their derivatives is expected to grow significantly over the next decade, driven by advancements in synthetic methodologies and increasing investment in pharmaceutical research.

In conclusion, 5-Bromocinnoline (CAS No. 24257-88-3) is a multifaceted compound with significant potential in various scientific and industrial applications. Its unique chemical structure and versatile reactivity make it an invaluable tool for researchers working on novel drug candidates and agrochemicals. As ongoing research continues to uncover new applications, the importance of this compound is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)